OVID is currently covered by 1 analysts with average potential upside of $4.3 (86.95%) backed by 13 price targets and 12 ratings. Documented since 14-Jul-2020. Analyst's average stock valuation to be materialised ratio is 7.14% with an average time for price targets to be met of 45.5 days.
Most recent stock forecast was given by YIGAL NOCHOMOVITZ from CITI on 29-Aug-2022.
Highest price target for OVID is 4, Lowest price target is 2, average price target is 3.
Currently, out of the existing stock ratings of OVID - 3 which are a Hold (100%)
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Hold
4
6 months 26 days ago
1/7 (14.29%)
$2.09 (48.60%)
91
Buy
5
2 years 24 days ago
0/2 (0%)
$6.5 (125.30%)
What is OVID(Ovid Therapeutics Inc) average time for price targets to be met?
Which analyst has the current highest performing score on OVID(Ovid Therapeutics Inc) with a proven track record?
